The application of gene therapy in autoimmune disease represents a novel us
e of this technology. The goal of gene therapy in the treatment of autoimmu
ne disease is to restore 'immune homeostasis' by countering the pro-inflamm
atory effects of the CD4(+) T cells in the lesions of autoimmunity. This ca
n be accomplished by adoptive therapy with transduced T cells which can spe
cifically home to the site of inflammation and secrete 'regulatory' protein
(s) to ameliorate the inflammation or by direct targeting of the retroviral
vector to activated T cells in the sites of inflammation. Transduction of
autoantigen recognizing CD4(+) T cells, to secrete anti-inflammatory produc
ts, may become the 'magic bullet' to combat the ravages of autoimmune infla
mmation and tissue destruction.